Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03906721 · ClinicalTrials.gov registry record · Phase 2

Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury

A Phase 2 study of Spinal Cord Injuries and Burn Injury, sponsored by Spaulding Rehabilitation Hospital.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT03906721 is a Phase 2 study of Spinal Cord Injuries and Burn Injury that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 30 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03906721, a Phase 2 study of Spinal Cord Injuries and Burn Injury, has completed, sponsored by Spaulding Rehabilitation Hospital.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The use of conditioning open-label placebo (COLP) will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid dose to diminish adverse effects as well as the risk of addiction associated with narcotic treatment.

Conditions Studied

Spinal Cord Injuries Burn Injury Polytrauma

Interventions

  • DRUG Placebo
  • DRUG Oxycodone
  • OTHER Essential Oil

Study Locations (1)

Massachusetts

  • Spaulding Rehabilitation Hospital - Charlestown

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-02-20
Est. Completion 2021-11-01
Phase Phase 2

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03906721

The ClinicalTrials.gov registry entry for NCT03906721 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT03906721 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03906721 about?

NCT03906721 is a clinical study titled "Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury". The use of conditioning open-label placebo (COLP) will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid dose to diminish adverse effects as well as...

What is the current status of trial NCT03906721?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2019-02-20. Estimated completion is 2021-11-01.

What conditions does trial NCT03906721 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Burn Injury, Polytrauma.

What interventions are being tested in trial NCT03906721?

The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), Essential Oil (OTHER).

Who is sponsoring clinical trial NCT03906721?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03906721 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Spinal Cord Injuries

All registered trials for this condition

Burn Injury

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.